Final phase II safety and efficacy results of study MC0452: Phase I/II trial of CCI 779 and bevacizumab in advanced renal cell carcinoma

Journal article

Peer reviewed

J. R Merchan, H. C Pitot, R Qin, G Liu, T. R Fitch, W. J Maples, J Picus and C Erlichman

Journal of clinical oncology, Vol.29(15_suppl), pp.4548-4548

2011-05-20

Metrics

6 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Final phase II safety and efficacy results of study MC0452: Phase I/II trial of CCI 779 and bevacizumab in advanced renal cell carcinoma
Creators: J. R Merchan
H. C Pitot
R Qin
G Liu
T. R Fitch
W. J Maples
J Picus
C Erlichman
Publication Details: Journal of clinical oncology, Vol.29(15_suppl), pp.4548-4548
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031598121102976